Himuka AM Pharma / Himuka AM Australia

himuka is a clinical-stage biotech company engaged in the research and development of novel therapies for unmet medical needs. himuka is conducting a phase 1 clinical trial of hm201, a novel adrenomedullin based peptide drug candidate developed for the treatment of inflammatory bowel disease.